HematologyNews.net

Hematology Xagena

Search results for "Venetoclax"

A phase 2 trial of the investigational medicine Venetoclax met its primary endpoint ( overall response rates ) in patients with relapsed / refractory or previously untreated chronic lymphocytic leukem ...